A major role for neutrophils in experimental bullous pemphigoid.

Bullous pemphigoid (BP) is an inflammatory subepidermal blistering disease associated with an IgG autoimmune response to the hemidesmosomal protein, BP180. Using a passive transfer mouse model, our group has shown previously that antibodies to the murine BP180 (mBP180) ectodomain are capable of triggering a blistering skin disease that closely mimics human BP. In this study, we investigated the role of neutrophils in the immunopathogenesis of this disease model. BALB/c mice depleted of circulating neutrophils by treatment with neutrophil-specific antibodies were no longer susceptible to the pathogenic effects of anti-mBP180 IgG. IgG and complement were deposited at the dermal-epidermal junction of these animals, but there was no evidence of inflammatory infiltration or blistering. C5-deficient mice, which are resistant to the pathogenic activity of anti-mBP180 IgG, could be made susceptible to this IgG-mediated blistering disease by intradermal administration of a neutrophil chemoattractant, IL-8 or C5a. Intraperitoneal injection of IL-8, which sequesters neutrophils in the peritoneal cavity, interferes with anti-mBP180-induced neutrophilic infiltration of the skin and prevented the development of BP disease in BALB/c mice. These findings provide the first direct evidence that neutrophils recruited to the skin via a C5-dependent pathway play an essential role in subepidermal blister formation in experimental BP, and suggest new directions for disease intervention.

[1]  A. Rot,et al.  Chemotactic potency of recombinant human neutrophil attractant/activation protein-1 (interleukin-8) for polymorphonuclear leukocytes of different species. , 1991, Cytokine.

[2]  T. Watanabe,et al.  Selective Depletion of Rat Neutrophils by In Vivo Administration of a Monoclonal Antibody , 1989, Journal of leukocyte biology.

[3]  P. Ward,et al.  Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. , 1982, The Journal of clinical investigation.

[4]  G. Till,et al.  The role of complement in experimental bullous pemphigoid. , 1995, The Journal of clinical investigation.

[5]  M. Mihm,et al.  Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. , 1978, The New England journal of medicine.

[6]  M. Mihm,et al.  Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. , 1982, The Journal of investigative dermatology.

[7]  Y. Takahashi,et al.  Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. , 1985, The Journal of investigative dermatology.

[8]  J. Schröder,et al.  Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin. , 1989, Immunology.

[9]  L. Dubertret,et al.  Cellular events leading to blister formation in bullous pemphigoid , 1980, The British journal of dermatology.

[10]  M. Cybulsky,et al.  Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. , 1991, Journal of immunology.

[11]  T. Hugli,et al.  Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. , 1994, The American journal of pathology.

[12]  M. Raffeld,et al.  Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1. , 1991, The Journal of investigative dermatology.

[13]  J. M. Lipton,et al.  Alpha-MSH peptides inhibit acute inflammation induced in mice by rIL-1 beta, rIL-6, rTNF-alpha and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. , 1992, Cytokine.

[14]  J. Schröder,et al.  Inflammatory properties of neutrophil-activating protein-1/interleukin 8 (NAP-1/IL-8) in human skin: a light- and electronmicroscopic study. , 1991, The Journal of investigative dermatology.

[15]  J. Voorhees,et al.  Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. , 1982, The New England journal of medicine.

[16]  P. Henson,et al.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. , 1978, Journal of immunology.

[17]  E. Unanue,et al.  Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice , 1993, Infection and immunity.

[18]  P. Ward,et al.  Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. , 1993, Journal of immunology.

[19]  D M Lewis,et al.  An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. , 1982, The Journal of investigative dermatology.

[20]  A. Ackerman Histologic Diagnosis of Inflammatory Skin Diseases , 1996 .

[21]  B. Dewald,et al.  In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. , 1989, The American journal of pathology.

[22]  D. Priebat,et al.  Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. , 1982, The Journal of investigative dermatology.

[23]  K. Hashimoto,et al.  Eosinophilic spongiosis in bullous pemphigoid. , 1984, Archives of dermatology.

[24]  R. Freeman,et al.  Herpes gestationis: clinical and histologic features of twenty-eight cases. , 1983, Journal of the American Academy of Dermatology.

[25]  J. Troy,et al.  Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid. , 1995, Journal of immunology.

[26]  D. Lewis,et al.  Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin. , 1980, The Journal of investigative dermatology.

[27]  N. Korman Bullous Pemphigoid , 1985, Dermatologic clinics.

[28]  E. Wilson-Jones,et al.  Eosinophilic spongiosis in pemphigus. A report of an unusual hitological change in pemphigus. , 1968, Archives of dermatology.

[29]  F. Cunha,et al.  IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. , 1991, Immunology.

[30]  K. Stenn,et al.  Histologic diagnosis of inflammatory skin diseases , 1982 .

[31]  J. Troy,et al.  A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. , 1993, The Journal of clinical investigation.

[32]  M. Cybulsky,et al.  Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric venules without altering L-selectin expression or leukocyte rolling. , 1993, Journal of immunology.

[33]  S. Ikeda,et al.  Experimental bullous pemphigoid in guinea pigs: the role of pemphigoid antibodies, complement, and migrating cells. , 1984, The Journal of investigative dermatology.

[34]  A. Cochran,et al.  Mononuclear cell infiltrates in bullous disease. , 1987, The Journal of investigative dermatology.

[35]  H. Tagami,et al.  Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement. , 1983, Acta dermato-venereologica.

[36]  A. Haas,et al.  cDNA cloning of a novel human ubiquitin carrier protein. An antigenic domain specifically recognized by endemic pemphigus foliaceus autoantibodies is encoded in a secondary reading frame of this human epidermal transcript. , 1992, The Journal of biological chemistry.